Immunovant Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $666.4M
Liabilities Breakdown FY2024
Total Liabilities: $48.6M
Asset Breakdown
Total Assets: $666.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $635.4M | 95.3% |
| Accounts Receivable | $5.3M | 0.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $462.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $25.2M | 3.8% |
Liabilities Breakdown
Total Liabilities: $48.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.2M | 14.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $41.5M | 85.3% |